Pharmacytimes: Condition Center: Hepatitis C http://www.pharmacytimes.com/condition-resources/hepatitisc/condition-rss Hepatitis C en-us Mon, 02 Mar 2015 08:33:09 UTC Mon, 02 Mar 2015 08:33:09 UTC Researchers Identify How Hepatitis Leads to Liver Cancer http://www.pharmacytimes.com/news/Researchers-Identify-How-Hepatitis-Leads-to-Liver-Cancer A recent study has identified how chronic hepatitis infection can pave the way to liver cancer. Fri, 06 Feb 2015 04:18:00 UTC How Hepatitis C Therapies are Changing Patient Treatment http://www.pharmacytimes.com/videos/How-Hepatitis-C-Therapies-are-Changing-Patient-Treatment Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment. Fri, 09 Jan 2015 07:48:40 UTC More Awareness of Hepatitis C Patients Needed http://www.pharmacytimes.com/news/More-Awareness-of-Hepatitis-C-Patients-Needed A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease. Wed, 24 Dec 2014 01:32:55 UTC Researchers Set to Study Hepatitis C Therapy in Children http://www.pharmacytimes.com/news/Researchers-Set-to-Study-Hepatitis-C-Therapy-in-Children Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C. Sat, 04 Oct 2014 01:40:59 UTC Polypharmacy Hinders HIV Drug Adherence http://www.pharmacytimes.com/news/Polypharmacy-Hinders-HIV-Drug-Adherence Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy. Sat, 27 Sep 2014 04:33:01 UTC Combination Treatment for HIV/HCV Coinfection Shown Effective in Phase 3 Trial http://www.pharmacytimes.com/news/Combination-Treatment-for-HIVHCV-Coinfection-Shown-Effective-in-Phase-3-Trial Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV. Tue, 16 Sep 2014 02:56:43 UTC Hepatitis C Patients with HIV Co-Infection Vulnerable to Serious Liver Disease Despite Antiretroviral Therapy http://www.pharmacytimes.com/news/Hepatitis-C-Patients-with-HIV-Co-Infection-Vulnerable-to-Serious-Liver-Disease-Despite-Antiretroviral-Therapy A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone. Fri, 23 May 2014 01:00:54 UTC Multiple Tactics Needed to Combat Hepatitis C in Young Drug Users http://www.pharmacytimes.com/news/Multiple-Tactics-Needed-to-Combat-Hepatitis-C-in-Young-Drug-Users With hepatitis C infections on the rise among young injection drug users, researchers have recommended a range of promising prevention tactics. Wed, 07 Aug 2013 04:16:31 UTC Task Force Recommends Hepatitis C Testing for Baby Boomers http://www.pharmacytimes.com/news/Task-Force-Recommends-Hepatitis-C-Testing-for-Baby-Boomers The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C. Tue, 09 Jul 2013 07:57:10 UTC CDC Urges All Baby Boomers to Get Tested for Hepatitis C http://www.pharmacytimes.com/news/CDC-Urges-All-Baby-Boomers-to-Get-Tested-for-Hepatitis-C Testing baby boomers could help identify more than 800,000 new cases of hepatitis C and address the largely preventable consequences of the condition. Fri, 08 Jun 2012 04:46:49 UTC Triple Therapy for Hepatitis C Can Be Cost-Effective http://www.pharmacytimes.com/news/Triple-Therapy-for-Hepatitis-C-Can-Be-Cost-Effective New triple-therapy regimens for hepatitis C are expensive, but they can be cost-effective for many patients. Mon, 27 Feb 2012 05:20:09 UTC Risk Factors for Hepatitis C http://www.pharmacytimes.com/podcasts/Risk-Factors-for-Hepatitis-C Fri, 24 Feb 2012 06:43:17 UTC New Drugs for Hepatitis C http://www.pharmacytimes.com/podcasts/New-Drugs-for-Hepatitis-C Fri, 24 Feb 2012 06:27:22 UTC The Promise of Interferon-Free Treatment Regimens for Hepatitis C http://www.pharmacytimes.com/podcasts/The-Promise-of-Interferon-Free-Treatment-Regimens-for-Hepatitis-C Fri, 24 Feb 2012 05:37:42 UTC New Hepatitis C Treatment http://www.pharmacytimes.com/videos/New-Hepatitis-C-Treatment Fri, 24 Feb 2012 04:53:59 UTC Hepatitis C: Know Your Status http://www.pharmacytimes.com/videos/Hepatitis-C-Know-Your-Status Fri, 24 Feb 2012 04:43:42 UTC Hepatitis C: The Basics http://www.pharmacytimes.com/videos/Hepatitis-C-The-Basics Fri, 24 Feb 2012 04:31:20 UTC All-Oral Hepatitis C Treatment in Trial http://www.pharmacytimes.com/news/All-Oral-Hepatitis-C-Treatment-in-Trial Could treatment for hepatitis C viral infection become an all-oral supplement? Tue, 21 Feb 2012 02:00:01 UTC Hepatitis C Virus Infection Caused in Transplant Recipients http://www.pharmacytimes.com/news/Hepatitis-C-Virus-Infection-Caused-in-Transplant-Recipients Organs and tissue donated by a Kentucky man infected with the hepatitis C virus causes disease transmission to multiple organ recipients. Tue, 21 Feb 2012 02:00:00 UTC Bringing Viral Hepatitis Federal Action Plan to Life http://www.pharmacytimes.com/news/Bringing-Viral-Hepatitis-Federal-Action-Plan-to-Life The Department of Health and Human Services action plan calls for better strategies and methods of treating and diagnosing viral hepatitis. Tue, 21 Feb 2012 02:00:00 UTC